379 related articles for article (PubMed ID: 33741422)
1. Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition.
You JH; Lee J; Roh JL
Cancer Lett; 2021 Jun; 507():40-54. PubMed ID: 33741422
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.
Lee J; You JH; Shin D; Roh JL
Theranostics; 2020; 10(17):7775-7786. PubMed ID: 32685019
[No Abstract] [Full Text] [Related]
4. Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer.
Ghoochani A; Hsu EC; Aslan M; Rice MA; Nguyen HM; Brooks JD; Corey E; Paulmurugan R; Stoyanova T
Cancer Res; 2021 Mar; 81(6):1583-1594. PubMed ID: 33483372
[TBL] [Abstract][Full Text] [Related]
5. A novel KDM5A/MPC-1 signaling pathway promotes pancreatic cancer progression via redirecting mitochondrial pyruvate metabolism.
Cui J; Quan M; Xie D; Gao Y; Guha S; Fallon MB; Chen J; Xie K
Oncogene; 2020 Jan; 39(5):1140-1151. PubMed ID: 31641207
[TBL] [Abstract][Full Text] [Related]
6. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
7. PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells.
You JH; Lee J; Roh JL
J Exp Clin Cancer Res; 2021 Nov; 40(1):350. PubMed ID: 34749765
[TBL] [Abstract][Full Text] [Related]
8. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
Kim EH; Shin D; Lee J; Jung AR; Roh JL
Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
Lee J; You JH; Kim MS; Roh JL
Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
11. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
[TBL] [Abstract][Full Text] [Related]
12. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
Lou W; Chen Y; Zhu KY; Deng H; Wu T; Wang J
Biol Pharm Bull; 2017 Aug; 40(8):1306-1313. PubMed ID: 28515374
[TBL] [Abstract][Full Text] [Related]
13. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
[No Abstract] [Full Text] [Related]
14. Mitochondrial pyruvate carrier 1 expression controls cancer epithelial-mesenchymal transition and radioresistance.
Takaoka Y; Konno M; Koseki J; Colvin H; Asai A; Tamari K; Satoh T; Mori M; Doki Y; Ogawa K; Ishii H
Cancer Sci; 2019 Apr; 110(4):1331-1339. PubMed ID: 30801869
[TBL] [Abstract][Full Text] [Related]
15. Lipid peroxidation-induced ferroptosis as a therapeutic target for mitigating neuronal injury and inflammation in sepsis-associated encephalopathy: insights into the hippocampal PEBP-1/15-LOX/GPX4 pathway.
Wang H; Xu L; Tang X; Jiang Z; Feng X
Lipids Health Dis; 2024 Apr; 23(1):128. PubMed ID: 38685023
[TBL] [Abstract][Full Text] [Related]
16. Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer.
Zhou X; Zou L; Chen W; Yang T; Luo J; Wu K; Shu F; Tan X; Yang Y; Cen S; Li C; Mao X
Pharmacol Res; 2021 Feb; 164():105305. PubMed ID: 33197601
[TBL] [Abstract][Full Text] [Related]
17. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
[TBL] [Abstract][Full Text] [Related]
18. Two human patient mitochondrial pyruvate carrier mutations reveal distinct molecular mechanisms of dysfunction.
Oonthonpan L; Rauckhorst AJ; Gray LR; Boutron AC; Taylor EB
JCI Insight; 2019 May; 5(13):. PubMed ID: 31145700
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ferroptosis in kidney tubular cell death under diabetic conditions.
Kim S; Kang SW; Joo J; Han SH; Shin H; Nam BY; Park J; Yoo TH; Kim G; Lee P; Park JT
Cell Death Dis; 2021 Feb; 12(2):160. PubMed ID: 33558472
[TBL] [Abstract][Full Text] [Related]
20. MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway.
Zou H; Chen Q; Zhang A; Wang S; Wu H; Yuan Y; Wang S; Yu J; Luo M; Wen X; Cui W; Fu W; Yu R; Chen L; Zhang M; Lan H; Zhang X; Xie Q; Jin G; Xu C
Cell Death Dis; 2019 Feb; 10(3):148. PubMed ID: 30770798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
